191 related articles for article (PubMed ID: 1678712)
1. The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine.
Ellenbroek BA; Artz MT; Cools AR
Eur J Pharmacol; 1991 Apr; 196(1):103-8. PubMed ID: 1678712
[TBL] [Abstract][Full Text] [Related]
2. One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists.
Jiang LH; Kasser RJ; Altar CA; Wang RY
J Pharmacol Exp Ther; 1990 Jun; 253(3):1198-205. PubMed ID: 1972751
[TBL] [Abstract][Full Text] [Related]
3. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
Jackson DM; Mohell N; Bengtsson A; Malmberg A
Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
[TBL] [Abstract][Full Text] [Related]
4. One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the rat.
Ashby CR; Hitzemann R; Rubinstein JE; Wang RY
Brain Res; 1989 Jul; 493(1):194-7. PubMed ID: 2570618
[TBL] [Abstract][Full Text] [Related]
5. Haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment.
Hu XT; Wang RY
Brain Res; 1989 May; 486(2):325-33. PubMed ID: 2786442
[TBL] [Abstract][Full Text] [Related]
6. Studies on D1 and D2 dopamine receptor involvement in conditioned taste aversions.
Asin KE; Montana WE
Pharmacol Biochem Behav; 1989 Apr; 32(4):1033-41. PubMed ID: 2572001
[TBL] [Abstract][Full Text] [Related]
7. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation.
Marin C; Chase TN
Eur J Pharmacol; 1993 Feb; 231(2):191-6. PubMed ID: 8095897
[TBL] [Abstract][Full Text] [Related]
9. The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indices.
Murray AM; Waddington JL
Eur J Pharmacol; 1990 Sep; 186(1):79-86. PubMed ID: 2149339
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia.
Ikeda H; Adachi K; Hasegawa M; Sato M; Hirose N; Koshikawa N; Cools AR
J Neural Transm (Vienna); 1999; 106(11-12):1205-16. PubMed ID: 10651114
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain.
O'Dell SJ; La Hoste GJ; Widmark CB; Shapiro RM; Potkin SG; Marshall JF
Synapse; 1990; 6(2):146-53. PubMed ID: 2237777
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.
Farde L; Nordström AL; Wiesel FA; Pauli S; Halldin C; Sedvall G
Arch Gen Psychiatry; 1992 Jul; 49(7):538-44. PubMed ID: 1352677
[TBL] [Abstract][Full Text] [Related]
13. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Sonsalla PK; Manzino L; Heikkila RE
J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
[TBL] [Abstract][Full Text] [Related]
14. The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs.
Ellenbroek BA; Peeters BW; Honig WM; Cools AR
Psychopharmacology (Berl); 1987; 93(3):343-8. PubMed ID: 2893411
[TBL] [Abstract][Full Text] [Related]
15. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
Reuss B; Unsicker K
Mol Cell Neurosci; 2001 Aug; 18(2):197-209. PubMed ID: 11520180
[TBL] [Abstract][Full Text] [Related]
16. Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats.
Ellison G; Johansson P; Levin E; See R; Gunne L
Psychopharmacology (Berl); 1988; 96(2):253-7. PubMed ID: 2906749
[TBL] [Abstract][Full Text] [Related]
17. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus.
Obuchowicz E
Neuropeptides; 1996 Oct; 30(5):471-8. PubMed ID: 8923510
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
Subramaniam S; Lucki I; McGonigle P
Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
[TBL] [Abstract][Full Text] [Related]
20. Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists.
Cory-Slechta DA; Widzowski DV
Brain Res; 1991 Jul; 553(1):65-74. PubMed ID: 1681979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
